Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Clinical pharmacokinetic study of panomifene described

Oct. 6, 1997

Gd-Tex in phase Ib: safety profile and maximum tolerated dose

Oct. 6, 1997

Femara launched in U.S.

Oct. 3, 1997

Sugen's angiogenesis inhibitor SU-5416 enters phase I

Oct. 3, 1997

Favorable phase II/III data for Targretin in CTCL reported at dermatology congress

Oct. 2, 1997

Safety profile of VRCTC-310 established in rabbits

Oct. 2, 1997

Camptosar available in Canada

Oct. 1, 1997

Matrix announces restructuring to focus on oncology products

Oct. 1, 1997

Inex seeks Canadian approval to commence Onco TCS trials for lymphoma

Sep. 30, 1997

Taxotere efficacy demonstrated in NSCLC, gastric cancer

Sep. 29, 1997

Popular Stories

Today's news in brief
BioWorld
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...